Aribio Lab Amends Stock Option Grant Report Reducing Grantees and Shares Due to Resignations

Aribio Lab amended its stock option grant report originally filed on March 27, 2023, effective June 30, 2026.
The amendment reduces grantees from 4 to 2 and granted shares from 80,000 to 35,000 due to employee resignations.
The exercise price was slightly adjusted from 5,756 KRW to 5,637 KRW following a capital increase, and total outstanding stock options decreased sharply from 652,000 to 138,168 shares.
This reflects cancellations of previously granted options; the new grant is minimal with a dilution impact of only 0.13% relative to total shares outstanding.
[AI Summary]The amendment to Aribio Lab's stock option grant is a routine update due to resignations, with negligible market impact. Dilution risk, capital allocation purpose, and governance are all neutral. The effect on the stock price is limited.